Skip to main content
Log in

The fine line of early ART eligibility and its consequences

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Bor J, et al. The Cost-Effectiveness of Early ART Initiation in South Africa: A Quasi-Experiment. 22nd Conference on Retroviruses and Opportunistic Infections : abstr. 1110, 23 Feb 2015.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

The fine line of early ART eligibility and its consequences. PharmacoEcon Outcomes News 725, 31 (2015). https://doi.org/10.1007/s40274-015-2045-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2045-6

Navigation